Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 14, 2022
Platinum-Based Chemotherapy 'Rechallenge' in Advanced Non-ovarian Solid MalignanciesJ Hack, S J CrabbClinical Oncology (Royal College of Radiologists (Great Britain))|September 11, 2002
Brain as sanctuary site of relapse in germ cell cancer patients previously treated with chemotherapyS J Crabb, J J McKendrick, G M MeadCurrent Cancer Drug Targets|December 23, 2009
Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discoveryA Ganesan, L Nolan, S J Crabb, et al.European Journal of Cancer Care|January 27, 2015
Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patientsC Chau, M Wheater, T Geldart, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|February 15, 2016
Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate CancerR Davda, S Hughes, R Jones, et al.British Journal of Cancer|August 30, 2008
Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?L Nolan, P W M Johnson, A Ganesan, et al.British Journal of Cancer|February 22, 2014
Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tractJ Douglas, A Sharp, C Chau, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2015
Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experienceC Chau, R Cathomas, M Wheater, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2017
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)A Bamias, K Tzannis, L C Harshman, et al.Pageof 1